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People afflicted with diseases such as retinitis pigmentosa and age-related macular degeneration
experience a decline in vision due to photoreceptor degeneration, which is currently unstoppable
and irreversible. Currently there is no cure for diseases linked to photoreceptor degeneration. Recent
experimental work showed that mesencephalic astrocyte-derived neurotrophic factor (MANF) can reduce
neuron death and, in particular, photoreceptor death by reducing the number of cells that undergo
apoptosis. In this work, we build on an existing system of ordinary differential equations that represent
photoreceptor interactions and incorporate MANF treatment for three experimental mouse models having
undergone varying degrees of photoreceptor degeneration. Using MANF treatment levels as controls, we
investigate optimal control results in the three mouse models. In addition, our numerical solutions match
the experimentally observed surviving percentage of photoreceptors and our uncertainty and sensitivity
analysis identifies significant parameters in the math model both with and without MANF treatment.
Keywords: optimal control, mesencephalic astrocyte-derived neurotrophic factor, photoreceptor
degeneration, apoptosis, model of ordinary differential equations.
1. Introduction
1.1 Background of photoreceptor degeneration
The most common forms of blindness in the world are treatable. In 2015, the World Health Organization
(WHO) estimated that approximately 253 million people in the world are vision impaired with 36
million blind and 217 million suffering from moderate to severe vision impairment. Over 80% of all
vision impairment can be avoided, prevented or cured except for blindness related to photoreceptor
degeneration (World Health Organization Vision Impairment and Blindness, 2017). Avoidable blindness
results from conditions that can be prevented or controlled if knowledge and interventions are available
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and applied in a timely manner or if the sight loss condition is successfully treated in order to restore
sight (e.g. cataract). While tremendous improvements have been made in some areas of blindness
prevention and control, trends in an ageing and growing population coupled with the increase in myopia
and diabetic retinopathy are counteracting the decrease in blindness catalysed by the target goal of the
WHO (to decrease blindness by 25% from 2010 to 2020). The global cost of blindness is projected
to double by 2020 from the $80 million per year spent today (Bourne et al., 2017; World Health
Organization Vision Impairment and Blindness, 2017; World Health Organization Vision Media Center,
2018). Blindness is predicted to increase threefold by 2050 (from 38.5 million people in 2020 to 115
million in 2050) (Pizzarello et al., 2004).
However, blindness due to degeneration of the photoreceptors still has no cure. The most common
forms of blindness caused by photoreceptor degeneration include age-related macular degeneration
(AMD) and untreated retina detachment (due to trauma). Photoreceptor degeneration also occurs in
retinitis pigmentosa (RP), which is the leading cause of hereditary blindness. RP is a heterogeneous
group of diseases that typically manifests itself between adolescence and early adulthood, affecting
approximately 1 in 4000 individuals (Besharse & Bok, 2011; Mohand-Said et al., 2001; Shintani et al.,
2009). To date, more than 45 gene mutations have been identified, each of which causes RP, and
all are seen to be present in the rod photoreceptor or the retinal pigment epithelium (RPE) (Hamel,
2006; Phelan & Bok, 2000). These genes are mostly responsible for encoding proteins involved in
the phototransduction cascade, the photoreceptor structure or the visual cycle (Busskamp et al., 2010;
Chalmel et al., 2007; Hartong et al., 2006; Malanson & Lem, 2009; Shen et al., 2005; Shintani et al.,
2009). Even in members of the same family carrying the exact same mutation, the age of onset,
the disease progression and the characteristics of RP vary dramatically among patients (Besharse
& Bok, 2011; Shen et al., 2005; Wong, 1997). Rod death is a hallmark of the disease and results
in night blindness yet preventing degeneration of the rods has proven difficult given the myriad of
mutations that cause the disease. However, in spite of the wide range of mutations that ultimately
result in rod degeneration, the degeneration of the healthy cones inevitably follows. Since it is the cone
photoreceptors that are responsible for day vision, colour vision and accuity, it is this secondary death
wave (in which the cones die) that has generated a tremendous amount of research (Besharse & Bok,
2011; Hartong et al., 2006; Shen et al., 2005; Shintani et al., 2009). The secondary death wave typically
begins when approximately 95% of the rods have died (Camacho et al., 2016a,b). A recent discovery
found that the rods release a protein, the rod-derived cone viability factor (RdCVF), that facilitates
glucose uptake by the cones, and therapies involving this factor hold promise (Aït-Ali et al., 2015;
Léveillard & Sahel, 2010; Sahel, 2005; Yang et al., 2009).
In terms of sight, light passes through the cornea, pupil and lens and ultimately hits the retina in the
back of the eye. This is where phototransduction begins; the light sensitive rod and cone photoreceptors
in the retina receive the light impulse and begin the vision process to transmit the signal to the brain.
The rods and cones are separate entities in close proximity in the retina and receive their essential
supplies from the choroid via the adjacent RPE. Thus, it is important to understand the interactions
within these specialized cells that form a functional unit that is critical for sight (Strauss, 2005). The
visual cycle and process by which a light signal is received by the eye and transmitted to the brain is
well understood (Keener & Sneyd, 2008; Oyster, 1999). In order to be sensitive to light signals and the
frequency with which light is received, the photoreceptors undergo a tremendous amount of stress on a
daily basis. The rods and cones are equipped to deal with this stress through periodic shedding at the
distal tip (near the RPE) and continuous renewal at the basal end of their outer segments (OS), which
are made up of discs (Bok, 1985; Hendrickson, 2008; David, May, 2002). Roughly 10% of each OS is
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also facilitates renewal as it delivers essential proteins and growth factors to the rods and cones. The
balance of shed and renewed discs ensures that the overall length of the OS remains roughly constant
over a day. Neural degeneration of the photoreceptors that typically results from genetic defects and
mutations (such as in RP) are implicated in disturbances of the shedding and renewal processes resulting
in abnormal photoreceptor OS length and thus promoting the complete disappearance of the rods and
cones (Mohand-Said et al., 2001; Pallikaris et al., 2003). Changes can occur either inside or outside
a cell of a multicellular organism that trigger the cell to self-destruct. This is termed apoptosis and
is sometimes referred to as programmed cell death. Additionally, apoptosis is observed to be another
process of photoreceptor death in RP and other diseases in which photoreceptor death occurs (Kernan
et al., 2007).
1.2 Treatment options and mesencephalic astrocyte-derived neurotrophic factor
There is no method of stopping photoreceptor death. Experimentalists have been undertaking a range
of methods that attempt to stop photoreceptor degeneration. Non-invasive methods that have been
pursued involve supplementation, e.g. with vitamin A and high doses of omega-3 fatty acid (including
Docosahexaenoic acid (DHA)) (Berson, 1993). Gene therapy has recently gained much attention as
researchers attempt to correct mutated genetic material in the rods with the insertion of healthy genes.
In photoreceptor degeneration caused by RP, treatments that do not target a specific mutation have more
promise given the heterogeneity of this inherited disease. Stem cell therapy is also being explored to see
if stem cells injected into the retina can be persuaded to differentiate into retinal cells. They would then
have the potential to replace damaged or missing retinal cells, which is very promising since retinal cells
are not born in a mature retina and are thus not replaced by the body after they have died. One common
mechanism of photoreceptor cell death in the above maladies is apoptosis, and researchers have pursued
methods to better understand and possibly prevent apoptosis.
In 2003, Petrova et al. (2004) discovered the secreted protein mesencephalic astrocyte-derived neu-
rotrophic factor (MANF). In the central nervous system, astrocytes and neurons interact functionally to
mediate processes such as neuroprotection. An important group of secreted proteins, these neurotrophic
factors help regulate the life and death of neurons. Astrocytes produce neurotrophic molecules that affect
neuronal development and survival, among other things, and the astrocyte-derived MANF is part of a
new class of therapeutics specifically used to treat diseases of the central nervous system. A key benefit
of MANF is that it can prevent apoptosis regardless of the cause and therefore potentially may be able
to cure diseases affecting neurons, such as RP or Parkinson’s disease, without knowing the fundamental
cause of this degeneration. Neurotrophic factors, including MANF, prevent apoptosis and regulate the
number of neurons innervating the target tissue (Lindholm & Saarma, 2010).
In 2016, Neves et al. (2016) demonstrated that MANF prevents apoptosis in the photoreceptors of
three different mouse models (i.e. three types of mice, each strain bred for a certain genetic makeup).
As apoptosis is the cause of a large number of photoreceptor deaths in AMD, RP and untreated retina
detachment, this finding has potential for significant impact in preventing photoreceptor degeneration.
While the experiments showed remarkable results in prevention of photoreceptor death due to genetic
and non-genetic factors, MANF did not prevent all of the photoreceptors from degenerating. In addition,
possible effects of overtreatment have not been explored systematically. Thus, it is important for
researchers to investigate alternative treatments or improve existing ones that target other aspects of
photoreceptor apoptosis and degeneration.
In this paper, we extend the mathematical model in Camacho et al. (2010), Camacho et al. (2016b),
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the photoreceptors and their trophic pool containing nutrients, metabolites, glucose, water, ions and
other essential growth factors. In Camacho et al. (2014), we considered drug treatment of RP through
the RdCVF factor where our numerical results agreed with experimental results in mice showing 40%
cone rescue effect in a rod free retina. Now, we introduce drug treatment through the MANF factor
in the three photoreceptor degeneration mouse models in Neves et al. (2016) having varying degrees
of retinal degeneration (two models due to light exposure with different levels of photosensitivity and
the third model due to RP) and consider MANF as the control variable. In doing so, we introduce
apoptosis to the system. Our goal is to study the influence of MANF on preventing photoreceptor
death through a mathematical model with optimal control techniques and make comparisons with
experimental results given in Neves et al. (2016). Section 2 introduces the new mathematical model
along with the optimal control formulation, and in Section 3 the first-order necessary conditions of the
optimal control problem are given. In Section 4, we discuss numerical results via sensitivity analysis
with partial rank correlation coefficients (PRCC) of parameter values used in the mathematical model,
and follow-up with a discussion of results in the solution of the optimal control problem for all three
mouse models. Finally, Section 5 gives a brief discussion of the conclusions.
2. Mathematical model
In this section, we initially introduce the system of differential equations governing the photoreceptor
interactions, followed by a discussion of the optimal control problem on the three mouse models. The
mathematical models in Camacho et al. (2010, 2016b) and Camacho & Wirkus (2013) describe the
interactions between the nutrient-containing trophic pool and the three populations of photoreceptors:
the cones and two types of rods, where the rods are divided into two populations based on their
phenotype. All three photoreceptor populations and the trophic pool are functions of time t and defined
as follows:
Rn(t) : population of normal rods,
Rm(t) : population of mutated rods,
C(t) : population of cones and
T(t) : trophic pool (RPE).
Here we consider Rm to represent those rods that have begun to express the RP gene mutation
and thus have had some aspect of their functionality compromised Camacho & Wirkus (2013). For
the three photoreceptor populations, we consider the units to be ‘number of cells’. Fractions of a cell
are interpreted as the photoreceptor outer segment discs and as the nutrients (such as growth factors,
metabolites, ions and water) for the trophic pool (Frasson et al., 1999; LaVail et al., 1998; Li et al.,
2010; Longbottom et al., 2009; Murakami et al., 2008; Strauss, 2005; Wenzel et al., 2005). Because the
trophic pool is mediated by the RPE, we view the RPE cells as a proxy for the trophic pool (Camacho
et al., 2010, 2016a,b; Camacho & Wirkus, 2013). The system of differential equations modelling these
interactions is given by
Ṙn = Rn(anT − μn − m) (1)
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Ċ = C(acT − μc + dnRn + dmRm) (3)
Ṫ = T(Γ − kT − βnRn − βmRm − γ C), (4)
where the parameters are nonnegative and define various physiological mechanisms and processes; see
Table 1. Briefly, the ai terms represent renewal rates, m represents the rate of phenotypic expression of
the mutation, di represent the one-way help provided by the rods to the cones, Γ is the inflow rate of
nutrients into the trophic pool, k limits the capacity of this inflow and βi, γ are the removal of nutrients
by rods and cones from the trophic pool. Additionally, the product of T with a photoreceptor population
signifies the consumption of nutrients by the respective populations. We note the use of the parameters
μn, μm and μc, which describe decay rates in the respective populations of the normal rods, mutated
rods and the cones, and which will be further described below. A thorough analysis of the equilibrium
in (1)–(4) and their stability was done in Camacho & Wirkus (2013). In particular, equilibria of the form
(R∗n, R∗m, C∗, T∗) were found with only one equilibrium being stable for any given set of parameters in
the physiologically observed parameter regions. Two steady-state values that occur for the parameters
in the three photoreceptor degeneration mouse models are R∗n + R∗m = 0, C∗ = 0, T∗ = 0 (where both
rods and cones survive) and R∗n = R∗m = C∗ = 0, T∗ = 0 (where rods and cones both die).
Now we introduce apoptosis into the system of differential equations. Hence, the parameters μn, μm
and μc in equations 13 are rewritten to explicitly include contributions from shedding (replaced by
renewal) and apoptosis (permanent loss):
μn = μns + μna (5)
μm = μms + μma (6)
μc = μcs + μca, (7)
where, e.g. μns describes the shedding rate of the normal rods, and μna describes the apoptosis rate of
the normal rods. Substituting (5)–(7) into (1)–(4) yields the new system of differential equations for our
mathematical model under the study:
Ṙn = Rn(anT − μns − m) − μnaRn (8)
Ṙm = Rm(amT − μms) + mRn − μmaRm (9)
Ċ = C(acT − μcs + dnRn + dmRm) − μcaC (10)
Ṫ = T(Γ − kT − βnRn − βmRm − γ C). (11)
2.1 Optimal control problem formulation
Based on our previous discussion on experimental results conducted by Neves et al. (2016), treatment
with MANF prevents apoptosis. Thus, we use optimal control theory to find treatment strategies
applying MANF to three mouse models with varying degrees of retinal degeneration. We will call
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Table 1 Parameter value ranges for system (12)-(15); the values were calibrated for a mouse model
in Camacho et al. (2016b). The variables C, Rn, Rm, T represent populations of cells
Parameter Description Units Source
Γ ∈ [4.55, 5.21] Total inflow rate into thetrophic factor T days−1
Camacho et al. (2016b);
Guérin et al. (1993)
k ∈ [1.95, 16.0] × 10−4 Limiting capacity oftrophic factors (T·days)−1
Camacho et al. (2016b);
Guérin et al. (1993)
βn ∈ [2.09, 3.88] × 10−8 Constant per cell rate atwhich Rn withdraws T (Rn·days)
−1 Camacho et al. (2016b);
Guérin et al. (1993)
βm ∈ [2.44, 3.78]×10−8 Constant per cell rate atwhich Rm withdraws T (Rm·days)
−1 Camacho et al. (2016b);
Guérin et al. (1993)
γ ∈ [3.5, 18.1] × 10−6 Constant per cell rate atwhich C withdraws T (C·days)−1
Camacho et al. (2016b);
Guérin et al. (1993)
m ∈ [1.1, 466] × 10−3 Rate of Rn losingsignificant functionality days−1 Camacho et al. (2016b)
dn ∈ [3.28, 5.47] × 10−9 Constant per cell rate atwhich Rn helps C (C·days)
−1 Guérin et al. (1993);
Léveillard et al. (2004)
dm ∈ [1.01, 3.79]×10−9 Constant per cell rate atwhich Rm helps C (C·days)
−1 Léveillard et al. (2004)
μns ∈ [.0912, .1075] OS shedding rate of Rn days−1
Camacho et al. (2016b);
Murakami et al. (2012);
Young (1971)
μms ∈ [.0995, .119] OS shedding rate of Rm days−1 Murakami et al. (2012)
μcs ∈ [.120, .125] OS shedding rate of C days−1
Jonnal et al. (2010);
Murakami et al. (2012);
Young (1971)
an ∈
[4.297, 5.617] × 10−6
Per cell normal rod
renewal rate (T·days)−1
Camacho et al. (2016b);
Guérin et al. (1993)
am ∈
[1.831, 6.101] × 10−6
Per cell mutated rod
renewal rate (T·days)−1
Camacho et al. (2016b);
Guérin et al. (1993)
ac ∈
[4.383, 5.239] × 10−6 Per cell cone renewal rate (T·days)
−1 Camacho et al. (2016b);
Guérin et al. (1993)






Matsumoto et al. (2014);
Neves et al. (2016);
Wenzel et al. (2001)






Matsumoto et al. (2014);
Neves et al. (2016);
Wenzel et al. (2001)
μna, μma ∈ [0.14, 0.31] Per cell rod apoptosis rate,Pde6bRd1 mouse days−1
Neves et al. (2016);
Punzo et al. (Jan, 2009)
μca ∈ [0, 0.01] Per cell cone apoptosisrate, Pde6bRd1 mouse days−1
Neves et al. (2016);
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the percentage of decrease in apoptosis from a corresponding level of the MANF treatment and is
incorporated into the state equations to affect apoptosis in the three photoreceptor populations:
Ṙn = Rn(anT − μns − m) − μna(1 − u)Rn (12)
Ṙm = Rm(amT − μms) + mRn − μma(1 − u)Rm (13)
Ċ = C(acT − μcs + dnRn + dmRm) − μca(1 − u)C (14)
Ṫ = T(Γ − kT − βnRn − βmRm − γ C). (15)
We note that the control variable u is dimensionless; a value of u represents the percentage of decreasing
effect on apoptosis due to the corresponding dosage while u = 0 represents either completely ineffective
treatment or no applied treatment. To achieve high population levels of rods and cones while not





α1Rn + α2Rm + α3C




where the first terms represent a weighted sum of the rods and cones. The positive weight ε represents
the importance of applying moderate treatment. The nonnegative weights α1, α2 and α3 represent the
importance of maximizing the populations of rods (Rn and Rm, respectively) and cones. Experiments
involving MANF are relatively new and we have not found any that discuss toxicity of MANF. However,
we assume that high levels of MANF will result in some level of toxicity and thus we use u2, but this
term will be small in relationship to the other terms since 0 < u < 1. The toxicity is assumed to be a
nonlinear function of the control and we choose a simple nonlinear function with a weight of ε/2 with




∣∣ u is measurable, umin ≤ u(t) ≤ umax, t ∈ [0, tf ]
}
, (17)
with umin ≥ 0 and umax < 1. Note that since the control u is bounded and the corresponding states are
bounded in the time interval, then the objective functional J(u) is bounded over the controls u in the
control set U (Lenhart & Workman, 2007).




The parameter value ranges for the optimal control problem are given in Table 1 and obtained either
from the literature or from parameter estimation via inverse problem methodology (Camacho et al.,
2016b). Details of the origin of these parameter values can be found in Camacho et al. (2016b) and the
references therein. The initial values for rods, cones and trophic pool in the RP mouse model Pde6bRd1
are taken as Rn(0) = 3 × 106, Rm(0) = 0.6 × 106, C(0) = 0.18 × 106, T(0) = 8400 (Camacho et al.,
2016b). For the non-RP mouse models BALB/cJ and C57BL/6, Rn(0) = 3.6 × 106 and Rm(0) = 0. The
specific parameter values for each mouse model are given in Section 4 since they are dependent on the
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3. First-order necessary conditions
To use Pontryagin’s maximum principle to solve the optimal control problem, we first define the
Hamiltonian H as


















T(Γ − kT − βnRn − βmRm − γ C)
)
,
where (λ1, λ2, λ3, λ4) are the adjoint functions of time t. The state variables Rn, Rm, T and C and the
controls are a priori bounded on the time interval [0, tf ], and the structure of the differential equation
system (12)–(15) gives the uniform boundedness of the derivatives of the state variables. These bounds
and the concavity of the functional J with respect to the control u are enough to guarantee the existence
of an optimal control. Then for an optimal control and corresponding states, we can apply Pontryagin’s
maximum principle.
Theorem 1 If u∗ and R∗n, R∗m, C∗, T∗ are optimal for problem (18), then there exist piecewise







anT − m − (1 − u)μna − μns







amT − (1 − u)μma − μms







acT − (1 − u)μca − μcs + dmRm + dnRn





= −Cλ3ac − λ2amRm − λ1anRn − λ4
(
Γ − γ C − 2kT − βmRm − βnRn
)
, (23)
with transversality boundary conditions λi(tf ) = 0 for i = 1, 2, 3, 4. The characterization for this optimal










We note that the characterization of u∗ depends on the three apoptosis rates, the population of rods and
cones and three adjoint functions. Hence, the characterization of u∗ and corresponding state and adjoint
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4. Numerical results and discussion
Recent experimental work by Neves et al. (2016) demonstrates that MANF prevents apoptosis in the
photoreceptors of mice. Utilizing the experimental results from three photoreceptor degeneration mouse
models in Neves et al. (2016), we compare the results and outputs of our mathematical model, both with
and without control, to clarify the key role of optimal control with MANF treatment. We first conduct
an uncertainty analysis and sensitivity analysis on the significance of the parameters, and then present
results on the optimal control problem.
The first two mouse models (the highly light-sensitive BALB/cJ and the normal C57BL/6 mouse
models) do not naturally exhibit photoreceptor degeneration; however, both undergo photoreceptor
degeneration with overexposure to high intensities of light. The light sensitive BALB/cJ strain lacks
the protective variant of the Rpe65 allele which causes the photoreceptors in mice to be very susceptible
to light induced retinal damage as opposed to the C57BL/6 strain which has the allele and thus retinal
damage requires high exposure to light (Neves et al., 2016). The third mouse model Pde6bRd1 has
manifested RP. Utilizing these three mouse models allows us to mathematically analyse the effect of
MANF treatment on both photoreceptor degeneration due to (1) RP via the Pde6bRd1 mouse model,
and (2) reactive oxidative species (ROS), a natural by-product of light absorption which leads to
accumulation of photo toxic products via a slow photoreceptor degeneration in the C57BL/6 mouse
model and a fast degeneration in the BALB/cJ mouse model.
The results of Neves et al. refer to the percentage of photoreceptors present after treatment and as
such we consider the % photoreceptors surviving as
number of photoreceptors surviving with MANF
initial number of photoreceptors
= (R̂n + R̂m + Ĉ)(tf )
(R̂n + R̂m + Ĉ)(t0)
(25)
number of photoreceptors surviving without MANF
initial number of photoreceptors
= (Rn + Rm + C)(tf )
(Rn + Rm + C)(t0)
, (26)
where R̂n, R̂m and Ĉ represent the amount of photoreceptors present at time t when optimal control is
applied. Thus, this formula provides the percentage of photoreceptors present after treatment. In each
of the MANF experiments, the results are presented as nuclei of the photoreceptors alive vs. in the
process of dying (Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive)
in a representative cross-section that allowed the researchers to count cell nuclei as well as measure
the thickness of the outer nuclear layer and inner nuclear layer (Neves et al., 2016). We extend these
ratios to the full mouse retina as done experimentally in Neves et al. (2016) to extract the number of
photoreceptors in the full retina and compare our results accordingly.
The parameter values used for the plots in the BALB/cJ, C57BL/6 and Pde6bRd1 mouse models are
μns = 0.103, μcs = 0.119, Γ = 4.93, an = 4.909 × 10−6,
ac = 5.12 × 10−6, βn = 2.50 × 10−8, dn = 3.4 × 10−9, γ = 4 × 10−6. (27)
Additionally, in the BALB/cJ and C57BL models we set
k = 2 × 10−4, dm = dn, μms = μns, am = an, βm = βn, m = 0,
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and in the Pde6bRd1 model we set
k = 2.25 × 10−4, dm = 6.91 × 10−9, βm = 2.29 × 10−8, μms = 0.0994,
am = 5.24 × 10−6, m = 3.68 × 10−1, α1 = α2 = 15, α3 = 10, ε = 1 (29)
for the simulations (Camacho et al., 2016b). For the first two mouse models without a mutation,
BALB/cJ and C57BL/6, we set m = 0 in (28) whereas for the mouse model Pde6bRd1, which has a
mutation that causes RP, we have m > 0 in (29). Previous work shows that RP mouse models have lower
nutrient availability which is represented by the slightly larger k-value (Camacho et al., 2016b; Camacho
& Wirkus, 2013). In the absence of treatment, the experiments in Neves et al. (2016) show death of the
photoreceptors over the given time frame of 2 days or 5 days with the amount of photoreceptor death
dependent on the particular mouse model. The above parameter sets give values in the range of the
experimental results of photoreceptor death in Neves et al. (2016) in the absence of control (i.e. absence
of treatment).
4.1 Sensitivity analysis
While experiments have shown that MANF can significantly decrease apoptosis in multiple mouse
models, previous experimental work in photoreceptor degeneration has shown other mechanisms are
important in affecting photoreceptor survival including balanced energy between consumption and
uptake; sufficient nutrients, glucose, RdCVF and neuroprotective factors (such as Pigment epithelium-
derived factor (PEDF), basic fibroblast growth factor (bFGF) and Ciliary neurotrophic factor (CNTF));
oxidative stress; and disruptions in the rapamycin (mTOR) pathway regulating nutrient demand,
and supply from the RPE (Camacho et al., 2016b; Li et al., 2010; Mohand-Saïd et al., 1998;
Mohand-Said et al., 2000, 2001; Punzo et al., Jan 2009, 2012; Strauss, 2005). Recently, research in
the coexistence of rods and cones has indicated that cellular metabolism associated with shedding and
renewal as well as aerobic glycolysis is critical in maintaining photoreceptors alive (Camacho et al.,
2016a). Thus, our goal is to utilize the results of this uncertainty analysis and sensitivity analysis to
better understand the relative role of MANF in preventing photoreceptor death and suggest potential
multifaceted treatment strategies for preventing photoreceptor death (and halting blindness) and examine
which processes (defined by the parameters in our mathematical model) have the most significant effect
in the presence of treatment with MANF and in the absence of such treatment.
In the cases of no treatment and of optimal treatment with MANF, we examine the significance of
the various parameters on the output, defined by total photoreceptor population (Rn + Rm + C) at the
final time values used in the three mouse model experiments. In examining the sensitivity analysis of the
output to its parameters (including the initial conditions), we used the latin hypercube sampling (LHS)
with PRCC method described in Marino et al. (2008). We have a total of four initial conditions for the
four state variables and 17 parameters; see Table 1 for a description of the parameters. Together, each
of the parameters has a range of reasonable values that contain their baseline values given in (27)–(29).
For the apoptosis rates, we consider the range to be the baseline value ±10% with the baseline values of
μna = μma = μca = 0.65 for the BALB/cJ mouse model, μna = μma = μca = 0.35 for the C57BL/6
mouse model and μna = μma = 0.22, μca = 0 for the Pde6bRd1 mouse model. These numerical values
are based on experimental observations of apoptosis in Neves et al. (2016), Punzo et al. (Jan, 2009) and
Wenzel et al. (2001); death by apoptosis was nearly twice as much in the light-sensitive BALB/cJ as
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Fig. 1. PRCC plots without and with optimal control for the BALB/cJ mouse model. The panels, A and B, are the PRCC
values for the total photoreceptor (PR) populations without and with optimal MANF treatment, respectively. In comparing the
results without control (A) vs. with optimal control (B), there are no differences in the significant parameters present. However,
with treatment, the role of apoptosis (μna) has a decreased magnitude while the role of shedding and renewing OS (μns and an,
respectively) together with the nutrient supply and limiting characteristics of the nutrients (Γ and k, respectively) has an increased
magnitude.
is in days 7–12 of degeneration and this is the approximate apoptosis rate for rods over that period
(Camacho et al., 2016b; Neves et al., 2016; Punzo et al., Jan, 2009). Using these ranges we perform
LHS. All parameters satisfied the monotonicity conditions of the output as required for PRCC analysis
for all three mice models. For our PRCC analysis, we consider significant to be those parameters that
result in a PRCC value larger than 0.4 in absolute value with p-values less than 0.05. All p-values of the
parameters in Figs 1–3 presented here are less than 10−6.
Figures 1–3 demonstrate the significant effect that MANF has on apoptosis and suggests additional
parameters that can be targeted to prevent photoreceptor death. The parameters in our model define
various physiological processes and mechanisms (as described in Table 1) and thus parameters that
have a significant effect in the population of photoreceptors as illustrated by our sensitivity analysis
results may suggest potential therapies that are known to affect the processes/mechanisms represented
by these parameters in Figs 1–3 and summarized in Table 2. The characteristics of the mouse models
and the methods of the experiments in Neves et al. (2016) that were used in this work are summarized
in the first two rows of Table 3. In all of the results, increasing the initial number of rods significantly
affects the overall photoreceptor population. However this significance is not changed with MANF
treatment. We note that while retinal transplants or stem cells may be able to affect this number, using
them as potential treatments to prevent photoreceptor degeneration is still unclear as retinal transplants’
success has been very limited and mixed and the retina stem cell research is still in its infancy with no
differentiation of retina photoreceptors having been achieved to date. Currently there are no treatments
that can alter in a positive way the number of rods or cones as there is no spontaneous regeneration of
photoreceptors in a mature retina. For this reason we will limit our discussion of our sensitivity analysis
results to other significant parameters. At this point it is worth mentioning that the large number of rods
(3.6 × 106) compared with the cones (0.18 × 106) in the mouse retina eliminates the possibility of any
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Fig. 2. PRCC plots without and with optimal control for the C57BL/6 mouse model. The panels, A and B, are the PRCC
values for the total PR populations without and with optimal MANF treatment, respectively. In comparing the results without
control (A) vs. with optimal control (B), there are no differences in the significant parameters present. The magnitude of
apoptosis (μna) is lessened with treatment. However, the relative magnitude of the remaining parameters has not changed. When
degeneration in a non-diseased retina is slow, MANF treatment only affects the magnitude of apoptosis, unlike in the BALB/cJ
mouse model, even though the same treatments would work on both types of photoreceptor degeneration.
Fig. 3. PRCC plots without and with optimal control for the Pde6bRd1 mouse model. The panels, A and B, are the PRCC
values for the total PR populations without and with optimal MANF treatment, respectively. In comparing the results without
control (A) vs. with optimal control (B), the magnitude of apoptosis in the mutated rods (μma) is remarkably lessened and in the
normal rods (μna) is not significant. Thus, treating RP photoreceptors with MANF is very effective in eliminating the effects of
apoptosis. Shedding and renewing of OS for rods (μns, μms, anand am), the nutrient supply (Γ ), the limiting characteristics of the
nutrients (k) and the initial rod populations (Rn(0) and Rm(0)) play an important role in the overall photoreceptor population with
non-apoptosis parameters all being the same relative magnitude. Focus areas of treatment should alter these processes as shown
in Camacho et al. (2016a,b).
In the BALB/cJ mouse model (Fig. 1), focus areas of treatment, both with and without treatment
with MANF, should further reduce apoptosis, increase the nutrient supply (Γ ), decrease the limiting
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Table 2 Most significant parameters from sensitivity analysis results of mathematical model without
and with optimal control. The ↑ indicates that an increase in the given parameter will result in additional
photoreceptors surviving at time tf whereas ↓ indicates that a decrease in the given parameter will result




tf Common significant parameters
without and with optimal control
Key differences with optimal
control vs. without
Figure
BALB/cJ 2 days ↓ μns, ↑ Γ , ↑ an, ↓ k, ↓ μna, ↑ Rn(0) μns, Γ , an, k are more significant 1
μna is less significant
C57BL/6 2 days ↓ μns, ↑ Γ , ↑ an, ↓ k, ↓ μna, ↑ Rn(0) μna is less significant 2
Pde6bRd1 5 days ↓ μns, ↓ μms, ↑ Γ , ↑ an, ↑ am, an is more significant, μma is less 3↓ k, ↓ μna, ↓ μma, ↑ Rn(0), ↑ Rm(0) significant, μna is not significant
by either decreasing the rate of OS shedding or increasing the rate of OS renewal and their associated
metabolism. In the C57BL/6 mouse model (Fig. 2), focus areas of treatment would be similar to those
for BALB/cJ but would potentially require less effort as degeneration in this type of mouse model is
slower. In the Pde6bRd1 mouse model (Fig. 3), in which RP is present and photoreceptor degeneration
begins approximately on the seventh day after birth, treatment with MANF removes the significance
of apoptosis for the normal rods (μna) and greatly reduces it for the mutated rods (μma). Thus, in the
presence of MANF, apoptosis is almost insignificant compared with other mechanisms that can further
reduce degeneration of photoreceptors; these are the shedding and renewing of OS for rods (μns, μms,
an and am), the nutrient supply (Γ ), the limiting characteristics of the nutrients (k) and the initial rod
populations (Rn(0) and Rm(0)).
The work of Camacho et al. (2016a,b) and Camacho & Wirkus (2013) revealed that increasing the
nutrient carrying capacity (Γ/k) and maintaining balanced energy consumption to energy uptake ratios
(μis/ai, for i = m, n, c) can significantly reduce photoreceptor degeneration in RP while the work in
Aït-Ali et al. (2015), Léveillard & Sahel (2010), Sahel (2005) and Yang et al. (2009) showed that the
rods are essential for maintaining cones alive by accelerating their glucose uptake via RdCVF. This body
of work supports the significance of all these parameters.
Across the three mouse models, the common parameters affecting the nutrient carrying capacity
(Γ/k) and the energy consumption to energy uptake ratios are always present. Affecting these
parameters in the nutrient carrying capacity has been the focus of numerous experiments as described
above. The importance of the balance of the energy consumption to uptake ratios without MANF
treatment has previously been suggested (Camacho et al., 2016b; Camacho & Wirkus, 2013), and its
significance remains even in the presence of MANF treatment. The key difference in the results of the
three mouse models seems to be in the role that apoptosis, and hence MANF treatment, plays. In our
PRCC analysis, we have shown that MANF has a significant role in preventing retinal degeneration in
all three mouse model and almost eliminates apoptosis in the Pde6bRd1 model.
4.2 Optimal control in three mouse models
The sensitivity analysis results demonstrated that apoptosis played the most significant role of all of









b/article-abstract/37/1/1/5363832 by The U
niversity of Texas R
io G
rande Valley user on 17 June 2020
14 E. CAMACHO ET AL.
Table 3 Summary of mouse models used by and experimental results of Neves et al. (2016). The
percentages of surviving photoreceptors predicted by the mathematical model are then compared and
the corresponding objective functional values, J, given
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day 12 after birth
Observed rate of apoptosis 0.65 per day for rods
and cones
0.35 per day for rods
and cones
0.22 per day for rods
only
% photoreceptors surviving
w/o treatment at time tf
[23.1%, 29.2%] [44.9%, 52.6%] [35.3%, 37.7%]
% photoreceptors surviving
with MANF treatment at
time tf
[51.7%, 56.3%] [56.2%, 63.5%] [64.4%, 68.1%]
Math model
% photoreceptors surviving
w/o treatment at time tf
28.5% 51.6% 36.4%
% photoreceptors surviving
with MANF treatment 54.6% 62.8% 65.9%
at time tf
Obj. func. value: J(u = 0) 2.16×107 2.27 ×107 1.75 ×108
Obj. func. value: J(uopt) 2.58×107 2.81 ×107 2.12 ×108
Obj. func. value: J(u = 0.9) 2.20×107 2.19 ×107 1.97 ×108
BALB/cJ model and the C57BL/6 model). Therefore, it is important to explore with specific examples
what a MANF-only treatment does to prevent the degeneration of photoreceptors. We note that an
overabundance of MANF is experimentally administered in each mouse model so that not all MANF
is utilized by the photoreceptors. Without any theoretical or experimental knowledge of toxicity levels
of MANF, we assume that the amount of photoreceptors preserved is maximal and thus aim to use
our mathematical model to find the minimum dose and strategy of dosing that will replicate these
results. Initially, we give a brief discussion of the algorithm solving the optimal control problem and
related results in connection with experimental research. Then we present the numerical solutions of
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We solve the optimality system (consisting of the state system in (12)–(15), the adjoint system
in (20)–(23) and the optimal control characterization in (24)) by the forward-backward sweep method
(FBSM) (Lenhart & Workman, 2007). The implementation of the stopping criteria for the FBSM checks
the convergence of successive iterates of controls, states and adjoints. For the numerical runs, we
choose the weights αi so that the model output with control matches the experimental observations
of the percentage of photoreceptors present at the end of treatment. The relative sizes of the four
weights in the objective functional is essential. We set ε = 1 and then the values of the other three
weights, αi, were chosen due to their rescue effects (percentage of surviving photoreceptors at the
final time) to lie in the corresponding ranges in the experiments. We also set α1 = α2 because
there is no experimental work or evidence suggesting that MANF affects the phenotypic rod types,
Rn and Rm, differently. As mentioned earlier, we theoretically assume the control u to take values,
0 ≤ u < 1. For the computations in this section, we let 0.1 ≤ u ≤ 0.9. The upper bound is present
because no studies have been done indicating the effectiveness of different dosages of MANF in the
photoreceptors. Therefore, we assume, arbitrarily, that MANF is at most 90% effective. Analogously, the
lower bound is present because experimental evidence suggests that even small levels of MANF have an
effect.
In the graphs of the optimal control solutions, Figs 4–6 initially show a small increase in the
photoreceptor populations, Rn, Rm and C, before it begins to decrease. We note that fractions of the
variables Rn, Rm and C are interpreted as OS discs and thus the variables represent the cumulative
number of photoreceptors as measured by both the total number of photoreceptors and respective heights
of each. As each photoreceptor height is a delicate balance of renewal at the basal end and shedding at
the distal tip and apoptosis directly affects an individual photoreceptor, the brief increase in Rn, Rm and
C at the beginning of some of the experiments when control is applied can be interpreted as a small
disruption in this balance. Previous work on the non-control equations has shown the presence of limit
cycles, interpreted as the rhythmic shedding and renewal of the OS, and thus a brief increase in the
non-control output also has a biological interpretation (Camacho et al., 2016c). In all of the graphs of
the control function u(t), note that u(t) reaches its bounds. With such bounds imposed, one does not
expect to have a smooth curve.
Table 3 summarizes the results of the experiments by Neves et al. (2016) and the output of the
mathematical model presented here. Figures 4–6 show plots of rods, cones and trophic pool over time
for the optimal control, without control (u = 0) and for the control fixed at its maximum value (u = 0.9).
All plots are within the range of the corresponding mouse model experiments; see Table 3.
In terms of our mathematical model, the parameters in equation (26) without control (u = 0) give
C∗ = R∗n = R∗m = 0, T∗ = 0 as the stable equilibrium. We again note that with optimal control we
take into account any potential toxicity associated with excessive treatment and overadministration of
MANF. The values of the objective functional for these three different control values (u = 0, optimal
u and u = 0.9) capture this effect, as maximizing the objective functional allows us to achieve high
population levels of photoreceptors while not applying excessive treatment.
5. Conclusion
Experimental results suggest that the prominent role played by MANF in preventing photoreceptor
degeneration is due to apoptosis. It is thus crucial to have a better understanding of how such treatment
affects the system. We modified a mathematical model of photoreceptor degeneration to reflect the
role of apoptosis in three experimental mouse models considered in Neves et al. (2016) (representing
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Fig. 4. BALB/cJ mouse model results with ε = 1, α1 = 5, α2 = 5, α3 = 4 in equation (16). Parameters are given in (27)
with μna = μma = μca = 0.65. The objective functional value with optimal control is J = 2.577 × 107, without control
J = 2.162 × 107, and with maximum control (u = 0.9) J = 2.199 × 107. Each plot shows the results with optimal control,
without control (u = 0) and with maximal control (u = 0.9) for comparison. Top left: total rods vs. time. Top right: cones vs.
time. Bottom left: control u vs. time. Bottom right: trophic factor vs. time.
model). We examined the significance of various processes defined by the parameters of the systems
with and without MANF treatment as well as the optimal treatment levels for these three mouse
models. Our sensitivity analysis results showed the key role of apoptosis in affecting the overall
photoreceptor population with and without MANF treatment as well as the significance of the other
mechanisms/processes and how their significance is altered with the optimal MANF treatment. Here
the optimal treatment is the one given by the optimal control which maximizes the photoreceptors while
taking into account potential toxicity from overadministration of MANF, whose potential toxic levels are
still unknown. By identifying the most significant parameters and how these affect the population levels
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Fig. 5. C57BL/6 mouse model results with ε = 1, α1 = 5, α2 = 5, α3 = 2 in equation (16). Parameters are given in (27) with
μna = μma = μca = 0.35. The objective function value with control is J = 2.883 × 107, without control J = 2.724 × 107, and
with maximum control (u = 0.9) J = 2.195 × 107. Each plot shows the results with optimal control, without control (u = 0) and
with maximal control (u = 0.9) for comparison. Top left: total rods vs. time. Top right: cones vs. time. Bottom left: control u vs.
time. Bottom right: trophic factor vs. time.
researchers into potential treatment focus areas. This work gives insight into areas of treatment that can
be utilized in conjunction with MANF to magnify their effect of preventing photoreceptor degeneration.
For example, in the case of the BALB/cJ mouse model the effect of all significant processes (except
for apoptosis) is augmented in the presence of an optimal MANF treatment. In this case, potential
treatments that are currently being investigated and that balance energy between consumption and
uptake, elimination of any disruptions in shedding and renewal of OS and sufficient nutrient supply
(which includes glucose, RdCVF and neuroprotective factors such as PEDF, bFGF and CNTF) can be
combined with MANF treatment. (Camacho et al., 2016b; Li et al., 2010; Mohand-Saïd et al., 1998;
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Fig. 6. Pde6bRd1 mouse model results with ε = 1, α1 = 15, α2 = 15, α3 = 10 in equation (16). Parameters are given
in (27) with μna = μma = 0.22, μca = 0. The objective functional value with control is J = 2.120 × 108, without control
J = 1.753 × 108, and with maximum control (u = 0.9) J = 1.970 × 108. Each plot shows the results with optimal control,
without control (u = 0) and with maximal control (u = 0.9) for comparison. Top left: total rods vs. time. Top right: cones vs.
time. Bottom left: control u vs. time. Bottom right: trophic factor vs. time.
With parameter values chosen carefully based on previous work (Camacho et al., 2016b), the initial
and final population values from the model simulations of our optimal control model with MANF
treatment are in the ranges from experimental observations in Neves et al. (2016). Our results confirm
the importance of increasing the nutrient carrying capacity (Γ/k) and maintaining balanced energy
consumption to energy uptake ratios (μis/ai, for i = m, n, c) in reducing photoreceptor degeneration
in both diseased and non-diseased retinas, as well as the importance of the rods (Rn(0) and Rm(0)) in
preserving photoreceptors in RP retinas (Aït-Ali et al., 2015; Camacho et al., 2016a,b; Camacho &
Wirkus, 2013; Léveillard & Sahel, 2010; Sahel, 2005; Yang et al., 2009). Our control model can be
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photoreceptor degeneration. The results of this model suggest that MANF combined with additional
targeted treatment areas can be part of a treatment strategy to slow or stop the degeneration of the
photoreceptors regardless of the cause.
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